跳到主要内容

劳伦斯 H. 方

MD

泌尿系肿瘤
Cancer immunotherapist and laboratory head

Dr. 劳伦斯 方 is a medical oncologist who specializes in immunotherapy to care for cancer patients with an emphasis on genitourinary cancers (those involving the genital or urinary organs).

A physician-scientist, 方 studies new immunotherapies for cancer. He is nationally known for his work on cancer vaccines and immune checkpoint inhibitors (drugs that prevent an immune system response that can stop cancer cells from being destroyed). He has helped conduct numerous clinical trials (evaluations of potential new treatments using human volunteers) and is the principal investigator on multiple research projects that have received grants from federal agencies and private foundations. As the leader of UCSF's cancer immunotherapy program, he helps to develop new treatments through early-phase clinical trials of novel immunotherapies. His laboratory focuses on understanding why current treatments work in some patients but not others.

方 earned his medical degree at Stanford University. He completed a residency in internal medicine at the University of Washington. He completed an oncology fellowship at Stanford Medicine.

方 joined the UCSF faculty in 2001 and is the Efim Guzik Distinguished 教授 in Cancer Biology. He has published more than 100 peer-reviewed scientific articles and multiple book chapters. He has lectured nationally and internationally on cancer immunotherapy.

  • 教育

    Stanford University School of Medicine, MD, 1992

  • 派驻

    University of Washington, Internal Medicine, 1994

  • 奖学金

    斯坦福医学院,肿瘤,1997年

  • 委员会认证

    Medical Oncology, American Board of Internal Medicine

  • 职称,

    教授

My goal is to improve treatment of cancer through immunotherapy.

我在那里看病人 (4)

    我的评论

    4.9

    总体经验
    116年评级
    关于我们的流程
    2023年10月19日
    他即将离开加州大学旧金山分校
    2023年9月28日
    Dr.方 always makes me feel like I am part of his extended family. Always concerned and willing to thoughtfully explain in lay terms what Is going on in my body at every stage of my treatment and caregiving.
    2023年9月23日
    他是我有过的最好的供养者.
    2023年8月19日
    Dr. 方是最好的!
    2023年8月4日
    Dr. 方 is a thoughtful listener and always waits until I'm done speaking before he begins. Unusual compared to other doctors - especially outside ucsf
    2023年7月24日
    Dr. 方是最好的!
    2023年7月15日
    Very clear and informative answers and questions.
    2023年7月15日
    There are not enough accolades to describe Dr. 方 He is the best in all aspects of his care. 他是我的男人!
    2023年7月8日
    Dr. 方很了不起.
    2023年6月3日
    Dr. 方 is an excellent care provider in all aspects.
    2023年3月18日
    优秀的
    2023年3月3日
    Dr. 方 has always treated me with great respect as a patient and human being and I therefore trust him with my life.
    2023年2月9日
    响应 & 有爱心的 & 知识渊博的.
    2023年1月29日
    Dr. 方 listened to me and my wife's questions asked for clarifications and responded directly the questions.
    2023年1月26日
    Dr. 方是一位优秀的实践者. 也很有礼貌.
    2022年11月25日
    Dr. 方 is a great communicator he uses language with precision so his explanations are very clear and concise.
    2022年10月27日
    Dr. 方 is the gold standard of professionalism.Never met another physician who even comes close.
    2022年10月22日
    Dr. 方 is attentive and is a great communicator.
    2022年7月28日
    Dr. 方 is an exceptionally talented physician an gifted and inspiring leader with impeccable character. I feel honored to have him as my personal guide on my journey with UCSF.
    2022年7月14日
    Dr. 方 answered all my questions clear and concise. 有爱心的十大赌博平台排行榜.
    2022年7月14日
    Dr. 方 is one of my very favorite doctors. He u it s a calm quiet humble man who shows concern for my issues and us ready to offer explanations. 最好的!
    2022年4月16日
    Dr. 方 is consistently thorough responsive and caring.
    2022年2月3日
    Dr 方 listens well and provided ideas for possible therapies to treat my case ( prostate cancer)
    装饰墨丘利的节

    An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination ...

    招聘

    装饰墨丘利的节

    Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior ...

    A positive response is defined as a ≥40% increase in the number of infiltrating cluster of differentiation 3 (CD3) + T cells between the pre-treatment biopsy at baseline and the 后处理RP试样. 于是,出现了消极的反应...

    招聘

    装饰墨丘利的节

    Vactosertib With Durvalumab in Urothelial Carcinoma Failing Checkpoint Inhibition

    ORR由RECIST版本1.1

    招聘

    分享